Skip to main content
. 2021 Jun 14;12:684540. doi: 10.3389/fpsyg.2021.684540

Table 3.

Regression model of the impact of group condition on primary and secondary outcome measures with variance explained by pre-treatment measure included.

Variable Unstandardized coefficients [95% CI] Standardized coefficients Between-group effect size [95% CI]
B SE B β t p
BDI-II −5.48 [−10.53, −0.43] 2.57 −0.29 −2.13 0.03 0.63 [1.18, 0.07]
BBQ 2.86 [−5.29, 10.94] 4.13 0.07 0.68 0.49 0.15 [0.39, −0.70]
PHQ-9 −2.63 [−5.53, 0.28] 1.48 −0.27 −1.78 0.08 0.62 [1.16, 0.05]
GAD-7 −3.55 [−6.11, −1.00] 1.30 −0.38 −2.73 0.01 0.82 [1.37, 0.24]
AUDIT −1.29 [−2.53, −0.04] 0.63 −0.25 −2.03 0.04 0.54 [−1.09, 0.02]
ISI 0.13 [−2.92, 3.17] 1.54 0.01 0.08 0.93 0.07 [−0.48, 0.61]
IES-R −6.29 [−14.89, 2.31] 4.38 −0.21 −1.44 0.15 0.45 [1.00, −0.10]
PSS-14 −6.36 [−10.26, −2.45] 1.99 −0.39 −3.20 0.001 1.04 [1.61, 0.45]
DAR-5 −0.72 [−2.02, 0.58] 0.66 −0.12 −1.09 0.27 0.27 [0.81, −0.28]

Between-group effect sizes presented as Cohen’s d [95% CI] at post-treatment measure for primary and secondary outcomes, using adjusted means for post-treatment measures with controlling for associated pre-treatment measure and observed SDs.